Considerations in the development and validation of real-time quantitative polymerase chain reaction and its application in regulated bioanalysis to characterize the cellular kinetics of CAR-T products in clinical studies

被引：10
作者：
Yang, Tong-yuan [1 ]
Doddareddy, Rajitha [1 ]
机构：
[1] Janssen Res & Dev LLC, Janssen BioTherapeut, 1400 McKean Rd, Spring House, PA 19477 USA
来源：
BIOANALYSIS | 2021年 / 13卷 / 02期
关键词：
assay development and validation; CAR-T; cellular kinetics; qPCR; regulated bioanalysis; LIGAND-BINDING ASSAYS; PCR ASSAYS; CELLS; QUANTIFICATION; REVOLUTION; SUPPORT; DNA;
D O I：
10.4155/bio-2020-0221
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
Real-time quantitative polymerase chain reaction (qPCR) has become the standard method for monitoring cellular kinetics of CAR-T therapies with measurement of the CAR transgene copy numbers in peripheral blood mononuclear cells isolated from patients receiving the treatment. Unlike other biophysical and immunological methodologies for bioanalytical characterization of conventional small molecule drugs or protein biologics, there is no relevant regulatory guidance to date on the method development and validation for quantitative qPCR assays employed during clinical development of CAR-T products. This paper will provide an overview and considerations in the development and validation of a qPCR assay from sample extraction to assay parameters and its implementation in regulated bioanalysis for CAR-T or other types of cell therapies.
引用
收藏
页码：115 / 128
页数：14
相关论文
共 26 条
  • [11] Human Copy Number Variation and Complex Genetic Disease
    Girirajan, Santhosh
    Campbell, Catarina D.
    Eichler, Evan E.
    [J]. ANNUAL REVIEW OF GENETICS, VOL 45, 2011, 45 : 203 - 226
  • [12] Hedman Johannes, 2013, Methods Mol Biol, V943, P17, DOI 10.1007/978-1-60327-353-4_2
  • [13] Comparison of UV spectrometry and fluorometry-based methods for quantification of cell-free DNA in red cell components
    Khetan, Dheeraj
    Gupta, Nitesh
    Chaudhary, Rajendra
    Shukla, Jai Shankar
    [J]. ASIAN JOURNAL OF TRANSFUSION SCIENCE, 2019, 13 (02) : 95 - 99
  • [14] Challenges and opportunities in bioanalytical support for gene therapy medicinal product development
    Ma, Mark
    Balasubramanian, Nanda
    Dodge, Robert
    Zhang, Yan
    [J]. BIOANALYSIS, 2017, 9 (18) : 1423 - 1430
  • [15] Cellular kinetics of CTL019 in relapsed/refractory B-cell acute lymphoblastic leukemia and chronic lymphocytic leukemia
    Mueller, Karen Thudium
    Maude, Shannon L.
    Porter, David L.
    Frey, Noelle
    Wood, Patricia
    Han, Xia
    Waldron, Edward
    Chakraborty, Abhijit
    Awasthi, Rakesh
    Levine, Bruce L.
    Melenhorst, J. Joseph
    Grupp, Stephan A.
    June, Carl H.
    Lacey, Simon F.
    [J]. BLOOD, 2017, 130 (21) : 2317 - 2325
  • [16] O'Hara DM, 2013, BIOANALYSIS, V5, P2679, DOI [10.4155/BIO.13.241, 10.4155/bio.13.241]
  • [17] CD19-targeted CAR T-cell therapeutics for hematologic malignancies: interpreting clinical outcomes to date
    Park, Jae H.
    Geyer, Mark B.
    Brentjens, Renier J.
    [J]. BLOOD, 2016, 127 (26) : 3312 - 3320
  • [18] The Cellular Immunotherapy Revolution: Arming the Immune System for Precision Therapy
    Paucek, Richard D.
    Baltimore, David
    Li, Guideng
    [J]. TRENDS IN IMMUNOLOGY, 2019, 40 (04) : 292 - 309
  • [19] ENZYMATIC AMPLIFICATION OF BETA-GLOBIN GENOMIC SEQUENCES AND RESTRICTION SITE ANALYSIS FOR DIAGNOSIS OF SICKLE-CELL ANEMIA
    SAIKI, RK
    SCHARF, S
    FALOONA, F
    MULLIS, KB
    HORN, GT
    ERLICH, HA
    ARNHEIM, N
    [J]. SCIENCE, 1985, 230 (4732) : 1350 - 1354
  • [20] Development of a quantitative relationship between CAR-affinity, antigen abundance, tumor cell depletion and CAR-T cell expansion using a multiscale systems PK-PD model
    Singh, Aman P.
    Zheng, Xirong
    Lin-Schmidt, Xiefan
    Chen, Wenbo
    Carpenter, Thomas J.
    Zong, Alice
    Wang, Weirong
    Heald, Donald L.
    [J]. MABS, 2020, 12 (01)
123